Sartorius Stedim Biotech SA (DIM) — Cash Flow-to-Debt Ratio
Sartorius Stedim Biotech SA (DIM) has a Cash Flow-to-Debt Ratio of 0.05x as of March 2026, meaning its operating cash flow of €182.60 Million could theoretically repay 0% of its total liabilities (€4.05 Billion) in one year. See DIM free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sartorius Stedim Biotech SA Cash Flow-to-Debt Ratio (2005–2025)
Historical debt coverage capacity for Sartorius Stedim Biotech SA across 21 annual periods. Also explore Sartorius Stedim Biotech SA annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sartorius Stedim Biotech SA (2005–2025)
Year-by-year debt coverage analysis for Sartorius Stedim Biotech SA. For market capitalisation and broader financial context, see Sartorius Stedim Biotech SA stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | €538.60 Million | €3.89 Billion | ▼ -28.1% |
| 2024 | 0.19x | €815.10 Million | €4.23 Billion | ▲ +30.7% |
| 2023 | 0.15x | €746.40 Million | €5.07 Billion | ▼ -38.6% |
| 2022 | 0.24x | €612.30 Million | €2.55 Billion | ▼ -23.5% |
| 2021 | 0.31x | €695.97 Million | €2.22 Billion | ▲ +19.4% |
| 2020 | 0.26x | €416.88 Million | €1.59 Billion | ▼ -45.5% |
| 2019 | 0.48x | €310.13 Million | €642.79 Million | ▲ +11.8% |
| 2018 | 0.43x | €227.29 Million | €526.59 Million | ▲ +29.6% |
| 2017 | 0.33x | €174.69 Million | €524.45 Million | ▼ -8.1% |
| 2016 | 0.36x | €156.66 Million | €432.29 Million | ▲ +6.3% |
| 2015 | 0.34x | €142.79 Million | €418.92 Million | ▲ +12.8% |
| 2014 | 0.30x | €111.31 Million | €368.25 Million | ▲ +30.6% |
| 2013 | 0.23x | €90.11 Million | €389.39 Million | ▲ +69.9% |
| 2012 | 0.14x | €48.93 Million | €359.14 Million | ▼ -26.9% |
| 2011 | 0.19x | €60.59 Million | €325.04 Million | ▼ -25.4% |
| 2010 | 0.25x | €72.76 Million | €291.27 Million | ▼ -25.3% |
| 2009 | 0.33x | €91.86 Million | €274.66 Million | ▲ +98.8% |
| 2008 | 0.17x | €47.23 Million | €280.70 Million | ▲ +79.7% |
| 2007 | 0.09x | €26.02 Million | €277.96 Million | ▼ -62.3% |
| 2006 | 0.25x | €51.72 Million | €208.41 Million | ▲ +21.2% |
| 2005 | 0.20x | €43.85 Million | €214.18 Million | — |